Formulation

With more complex molecules filling company pipelines, is it time for lipid nanoparticles to finally shine?

How hot-melt extrusion can help develop a viable formulation for APIs with poor solubility.

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

A cell-free biologic could act as platform therapeutic for a variety of serious diseases.

What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.

What’s on the horizon for the field of nanomedicine?

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.

Free “virtual assistant” tools offer a starting point for formulation – and easier access to regulatory documentation and other enabling information.

Why are people still being prescribed giant tablets?